the promise of genetic diagnostics

Microarray technology enables the evaluation of the transcription activity of thousands of genes in one single test. Complex assay results from microarrays are quickly becoming commonplace in clinical practice providing healthcare professionals detailed information about subtypes of various diseases and their prognosis.

About Skyline Diagnostics
The company develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer.

Skyline Diagnostics products are currently available research only tools in the United States.

The development pipeline includes diagnostic tests for:

• Acute Myeloid Leukemia
• Multiple Myeloma
• Acute Lymphatic Leukemia
• Brain tumors